Structure−Activity Relationship and Antituberculosis Properties of 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 Inhibitors

Authors:

Abstract
No abstract available
Funding Information
  • South African Medical Research Council
  • Bill and Melinda Gates Foundation (OPP1066878)
  • University of Capetown
  • South African National Research foundation, The South African Research Chairs Initiative of the Department of Science and Innovation
  • Neville Isdell

This publication has 29 references indexed in Scilit: